(A) Cell lysates were prepared from the indicated PCa cell lines and subjected to Western blots in order to detect the level and activity of PLK1 protein using anti−PLK1 and anti−PLK1(pT210) …
Total RNA from control RWPE-1 (EV) and RWPE-1–PLK1 (PLK1) cells was subjected to real-time RT-PCR. AR mRNA levels were normalized to glyceraldehyde phosphate dehydrogenase (GAPDH) and are expressed …
(A) The effect of PLK1 upregulation in RWPE-1 cells on anchorage-independent growth in soft agar. RWPE-1–PLK1 (PLK1) cells and vector control (EV) cells were plated in soft agar and grown for 21 …
(A) Modulated PLK1 levels in PrEC cells. PrEC cells were infected with lentivirus encoding Flag-PLK1 (PLK1) or control vector (EV). PLK1 protein levels were determined by Western blot. (B) A …
(A) Representative phase-contrast images of control RWPE-1 and RWPE-1–PLK1 cells. Scale bar = 50 μm. (B, C) mRNA and protein expression of different EMT markers in RWPE-1–PLK1 cells (PLK1) and …
RWPE-1–PLK1 (PLK1) cells and vector control (EV) cells were left either unsynchronized (Asyn) or synchronized at G1, S, and M phases. The expression of EMT markers in these cells was examined by …
(A) Representative phase-contrast images of control PrEC (EV) and PrEC-PLK1 (PLK1) cells. Scale bar = 50 μm. (B, C) EMT marker mRNA and protein expression in PrEC cells (PLK1) and vector control …
(A) Two metastatic PCa cell lines (DU145 and C4-2B) were infected with lentiviral shRNA constructs that target either the 3’-UTR of endogenous PLK1 (shPLK1#1) or serve as a control (shCTL). …
(A) The effect of PLK1 downregulation on cell cycle distributions was analyzed by flow cytometric analysis. (B) The effect of PLK1 downregulation on apoptosis was determined by staining with annexin …
(A) Three metastatic PCa cell lines (PC3, C4-2B, and DU145) were infected with lentiviral shRNA constructs that target either the 3’-UTR of endogenous PLK1 (shPLK1#2) or serve as a control (shCTL). …
(A) The level and activity of PLK1 protein in ARCaPE and ARCaPM cells were examined by Western blotting analysis using anti-PLK1 and anti-PLK1(pT210) antibodies, respectively. β-actin was used as a …
RWPE-1 and ARCaPE cells were treated with a combination of TGF-β1 (4 ng/mL) and EGF (50 ng/mL) in the presence and absence of BI2536 (1 nM) for 5 days. The EMT marker expression and morphological …
(A) Expression of different EMT-inducing transcription factors was examined in control and PLK1-overexpressing RWPE-1 cells by quantitative real-time RT-PCR. mRNA expression of genes of interest was …
Protein levels of ZEB1 and ZEB2, Fra1, and activated and total ERK1/2 in PrEC (EV) and PrEC-PLK1 (PLK1) cells were determined by Western blotting.
(A) The effect of PLK1 overexpression on activation (phosphorylation) of ERK1/2 and MEK1/2 was determined by immunoblotting. (B−E) Control (EV) and PLK1-overexpressing (PLK1) RWPE-1 cells were …
(A, B) mRNA and protein expression of Fra1 were examined in control (EV) and PLK1-overexpressing (PLK1) RWPE-1 cells by real-time RT-PCR (A) and immunoblotting (B), respectively. The data are …
(A) The effects of PLK1 overexpression on the levels of total and phosphorylated CRAF were determined by immunoblotting. p/t: indicates densitometric intensity ratio of phosphorylated to total CRAF. …
(A) Co-immunoprecipitation of endogenous PLK1 and CRAF from HeLa cell lysates obtained under control conditions or following nocodazole treatment to arrest cells at M phase. (B) GST pull-down assay …
DU145 cells were infected with lentiviral shRNA constructs that target either the 3’-UTR of endogenous PLK1 (shPLK1#2) or serve as a control. WT or KM PLK1 was then re-expressed in PLK1 knockdown …